Dr. Boris Mannhardt

Boris Mannhardt is CEO at BIOCOM AG, a Berlin-based enterprise focusing on communication and consulting in the life sciences across Europe. BIOCOM has extensive knowledge and experience in all biotech areas, from the pharmaceutical and agricultural sectors to industrial production. Building on this, BIOCOM can offer a comprehensive range of services for companies and the public sector – wherever state-of-the-art biotechnology calls for specialised information and communication processes. Boris Mannhardt has a scientific background with a PhD in molecular biology.